384 related articles for article (PubMed ID: 23588311)
21. Role of Hepatic Drug Transporters in Drug Development.
Liu H; Sahi J
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S11-22. PubMed ID: 27385168
[TBL] [Abstract][Full Text] [Related]
22. Research Methods and New Advances in Drug-Drug Interactions Mediated by Renal Transporters.
Lin K; Kong X; Tao X; Zhai X; Lv L; Dong D; Yang S; Zhu Y
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446913
[TBL] [Abstract][Full Text] [Related]
23. Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity.
Alim K; Bruyère A; Lescoat A; Jouan E; Lecureur V; Le Vée M; Fardel O
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):259-271. PubMed ID: 33292029
[No Abstract] [Full Text] [Related]
24. Emerging transporters of clinical importance: an update from the International Transporter Consortium.
Hillgren KM; Keppler D; Zur AA; Giacomini KM; Stieger B; Cass CE; Zhang L;
Clin Pharmacol Ther; 2013 Jul; 94(1):52-63. PubMed ID: 23588305
[TBL] [Abstract][Full Text] [Related]
25. Transporter-enzyme interplay and the hepatic drug clearance: what have we learned so far?
Alluri RV; Li R; Varma MVS
Expert Opin Drug Metab Toxicol; 2020 May; 16(5):387-401. PubMed ID: 32228316
[No Abstract] [Full Text] [Related]
26. Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature.
Rodrigues AD; Rowland A
J Pharmacol Exp Ther; 2020 Mar; 372(3):308-319. PubMed ID: 31879375
[TBL] [Abstract][Full Text] [Related]
27. Utility of Quantitative Proteomics for Enhancing the Predictive Ability of Physiologically Based Pharmacokinetic Models Across Disease States.
Sharma S; Suresh Ahire D; Prasad B
J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S17-S35. PubMed ID: 33205430
[TBL] [Abstract][Full Text] [Related]
28. Effects of Drug Transporters on Pharmacological Responses and Safety.
Liu CX; Yi XL; Fan HR; Wu WD; Zhang X; Xiao XF; He X
Curr Drug Metab; 2015; 16(9):732-52. PubMed ID: 26630905
[TBL] [Abstract][Full Text] [Related]
29. Drug transporters in pharmacokinetics.
Petzinger E; Geyer J
Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):465-75. PubMed ID: 16532306
[TBL] [Abstract][Full Text] [Related]
30. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.
Schlessinger A; Welch MA; van Vlijmen H; Korzekwa K; Swaan PW; Matsson P
Clin Pharmacol Ther; 2018 Nov; 104(5):818-835. PubMed ID: 29981151
[TBL] [Abstract][Full Text] [Related]
31. Dealing with the complex drug-drug interactions: towards mechanistic models.
Varma MV; Pang KS; Isoherranen N; Zhao P
Biopharm Drug Dispos; 2015 Mar; 36(2):71-92. PubMed ID: 25545151
[TBL] [Abstract][Full Text] [Related]
32. Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humans.
Kitamura S; Maeda K; Sugiyama Y
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):617-28. PubMed ID: 18536908
[TBL] [Abstract][Full Text] [Related]
33. Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy.
Bechtold B; Clarke J
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):397-412. PubMed ID: 33339463
[No Abstract] [Full Text] [Related]
34. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
Patel M; Taskar KS; Zamek-Gliszczynski MJ
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
[TBL] [Abstract][Full Text] [Related]
35. [Transporter-mediated drug-drug interaction in renal and hepatic elimination processes].
Nagai J
Nihon Yakurigaku Zasshi; 2010 Jan; 135(1):34-7. PubMed ID: 20075569
[No Abstract] [Full Text] [Related]
36. Transporter-mediated tissue targeting of therapeutic molecules in drug discovery.
Zhou J; Xu J; Huang Z; Wang M
Bioorg Med Chem Lett; 2015 Mar; 25(5):993-7. PubMed ID: 25650254
[TBL] [Abstract][Full Text] [Related]
37. Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactions.
Lu C; Liao M; Cohen L; Xia CQ
Curr Drug Discov Technol; 2010 Sep; 7(3):199-222. PubMed ID: 20843292
[TBL] [Abstract][Full Text] [Related]
38. Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification System.
El-Kattan AF; Varma MVS
Drug Metab Dispos; 2018 May; 46(5):729-739. PubMed ID: 29496721
[TBL] [Abstract][Full Text] [Related]
39. Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.
Brouwer KL; Aleksunes LM; Brandys B; Giacoia GP; Knipp G; Lukacova V; Meibohm B; Nigam SK; Rieder M; de Wildt SN;
Clin Pharmacol Ther; 2015 Sep; 98(3):266-87. PubMed ID: 26088472
[TBL] [Abstract][Full Text] [Related]
40. Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
Evers R; Piquette-Miller M; Polli JW; Russel FGM; Sprowl JA; Tohyama K; Ware JA; de Wildt SN; Xie W; Brouwer KLR;
Clin Pharmacol Ther; 2018 Nov; 104(5):900-915. PubMed ID: 29756222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
